Home » Topics » Regulatory » EMA

EMA
RSS

CHMP recommends new indication for Herceptin in early breast cancer

March 25, 2011

CHMP adopts positive opinion on ViroPharma's Cinryze

March 22, 2011

EMA committee recommends new pediatric indication for Pfizer's Revatio

March 22, 2011

CHMP recommends approval of Eliquis for prevention of venous thromboembolic events

March 22, 2011

CHMP adopts positive opinion regarding new birth control pill NOMAC/E2

March 21, 2011

CHMP adopts negative opinion for Vectibix in combination with chemotherapy

March 21, 2011

CHMP recommends approval of Lucentis in new indication

March 21, 2011

Biovest's BiovaxID receives E.U. orphan drug status in mantle cell lymphoma

March 10, 2011

Pfizer's axitinib receives European orphan drug status in renal cell carcinoma

March 10, 2011

EMA accepts Insmed's pediatric investigation plan for Arikace

March 9, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 30, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...